A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer
Clinical trial NCT02034097 · WITHDRAWN
Trial details
- NCT number
- NCT02034097
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2014-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.